MedTrace Logo

Acute Pancreatitis and Coagulation Study

NCT05201053 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2026-05-01

No results posted yet for this study

Summary

The study aims to investigate pathophysiological changes in coagulation in relation to inflammation in patients with acute pancreatitis. Serum and plasma is sampled repeated days from admission. Analysis will be done after recruitment. Specific biomarkers accuracy for prediction of moderate and severer acute pancreatitis will be calculated.

Conditions

Interventions

DIAGNOSTIC_TEST

Exploratory for different markers

Test biomarkers for development of mild, moderate or severe disease

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Region Skane

    lead OTHER

Principal Investigators

  • Sara Regnér, MD, PhD · Region Skåne and Lund University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2022-05-31
Completion
2023-06-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201053 on ClinicalTrials.gov